Menstrual day P Midluteal day P
Patients with PCOS Control Patients with PCOS Control
Estradiol (Pg/ml) 43.1 ± 10.9 35 ± 10.5 0.623 333.1 ± 265.9 415.0 ± 375.5 0.148
Progesterone (ng/ml) 0.2 ± 0.2 0.1 ± 0.3 0.536 25.2 ± 26.5 31.5 ± 39.9 0.516
LF power (ms2) 787.8 ± 174.5 986.0 ± 251.7 0.030 677.3 ± 206.4 826.1 ± 174.7 0.009
HF power (ms2) 281.2 ± 115.4 564.5 ± 151.7 0.004 215.2 ± 67.4 480.9 ± 131.7 0.001
LF/HF  2.8 ± 0.9 2.0 ± 0.8 0.018 3.3 ± 1.5 1.9 ± 0.7 0.004
VLF power (ms2) 2182.2 ± 808.8 2824.2 ± 844.5 0.075 2071.8 ± 801.8 2330.2 ± 625.8 0.400
Total spectral power (ms2) 3199.9 ± 8363.7 4410.1 ± 834.5 0.056 2962.2 ± 951.7 3705.1 ± 954.5 0.044
SDNN (ms) 139.4 ± 29.5 155.0 ± 21.3 0.071 106.5 ± 25.5 129.2 ± 16.1 0.034
SDANN (ms) 119.5 ± 19.2 137.0 ± 21.6 0.107 104.5 ± 15.6 113.5 ± 17.7 0.289
SDNN index (ms) 56.1 ± 8.3 67.3 ± 7.1 0.035 57.1 ± 12.8 61.1 ± 8.1 0.201
RMSSD (ms) 31.8 ± 10.2 43.3 ± 15.5 0.012 30.0 ± 6.6 40.6 ± 11.5 0.049
pNN50 (ms) 10.9 ± 6.7 20.5 ± 11.5 0.017 9.2 ± 3.6 17.3 ± 8.1 0.043
Mean Heart Rate (BPM) 82.1 ± 7.1 77.7 ± 5.8 0.094 84.1 ± 2.5 78.0 ± 4.9 0.004
All variables are given mean ± SD. The variables were analyzed by Mann-Whitney U test. Two-tailed P value <0.05 was considered statistically significant
Table 3: The comparison of HRV indices in the menstrualy day and midlutealy day of ovulation iduction cycle between PCOS and control group.
Goto home»